Structure-based de novo design of ligands using a three-dimensional model of the insulin receptor

被引:17
|
作者
Tan, C
Wei, LH
Ottensmeyer, FP
Goldfine, I
Maddux, BA
Yip, CC
Batey, RA
Kotra, LP
机构
[1] Univ Toronto, Mol Design & Informat Technol Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Chem, Davenport Res Labs, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada
[4] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[5] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
基金
加拿大健康研究院;
关键词
insulin receptor; de novo ligand deign;
D O I
10.1016/j.bmcl.2004.01.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For the first time, a three-dimensional model of the insulin receptor is used in the de novo design of novel ligands that potentially mimic interactions of insulin at its receptor. Compound 4 competed with insulin as seen in autophosphorylation assays and inhibited up to 68% of IR autophosphorylation at 300 muM of 4 in 3T3IR cells induced by 1 nM insulin. This model provides a basis for the design of potent insulin receptor ligands. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1407 / 1410
页数:4
相关论文
共 50 条
  • [1] Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen
    Firth-Clark, S
    Willems, HMG
    Williams, A
    Harris, W
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (02) : 642 - 647
  • [2] De Novo Structure-Based Drug Design Using Deep Learning
    Krishnan, Sowmya Ramaswamy
    Bung, Navneet
    Vangala, Sarveswara Rao
    Srinivasan, Rajgopal
    Bulusu, Gopalakrishnan
    Roy, Arijit
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (21) : 5100 - 5109
  • [3] A three-dimensional model of CYP19 aromatase for structure-based drug design
    Karkola, Sampo
    Hoeltje, Hans-Dieter
    Wahala, Kristiina
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 105 (1-5): : 63 - 70
  • [4] Structure-based design of adenosine receptor ligands
    Jacobson, Kenneth A.
    Stevens, Raymond C.
    Abagyan, Ruben
    Deflorian, Francesca
    Gao, Zhan-Guo
    Gakh, Andrei A.
    Tosh, Dilip K.
    Kumar, T. S.
    Xu, Fei
    Katritch, Vsevolod
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [5] Structure-based de novo design: Fantasy or opportunity?
    Chen, Huifen
    Chang, Man
    Bikker, Jack Andrew
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 93 - 93
  • [6] A genetic algorithm for structure-based de novo design
    Scott C.-H. Pegg
    Jose J. Haresco
    Irwin D. Kuntz
    [J]. Journal of Computer-Aided Molecular Design, 2001, 15 : 911 - 933
  • [7] A genetic algorithm for structure-based de novo design
    Pegg, SCH
    Haresco, JJ
    Kuntz, ID
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (10) : 911 - 933
  • [8] De novo structure-based design of anion receptors
    Hay, Benjamin P.
    [J]. CHEMICAL SOCIETY REVIEWS, 2010, 39 (10) : 3700 - 3708
  • [9] RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design
    Wang, Mingyang
    Hsieh, Chang-Yu
    Wang, Jike
    Wang, Dong
    Weng, Gaoqi
    Shen, Chao
    Yao, Xiaojun
    Bing, Zhitong
    Li, Honglin
    Cao, Dongsheng
    Hou, Tingjun
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9478 - 9492
  • [10] Structure-based design of bitopic ligands for the µ-opioid receptor
    Abdelfattah Faouzi
    Haoqing Wang
    Saheem A. Zaidi
    Jeffrey F. DiBerto
    Tao Che
    Qianhui Qu
    Michael J. Robertson
    Manish K. Madasu
    Amal El Daibani
    Balazs R. Varga
    Tiffany Zhang
    Claudia Ruiz
    Shan Liu
    Jin Xu
    Kevin Appourchaux
    Samuel T. Slocum
    Shainnel O. Eans
    Michael D. Cameron
    Ream Al-Hasani
    Ying Xian Pan
    Bryan L. Roth
    Jay P. McLaughlin
    Georgios Skiniotis
    Vsevolod Katritch
    Brian K. Kobilka
    Susruta Majumdar
    [J]. Nature, 2023, 613 : 767 - 774